| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| domiphen | [no description available] | medium | 1 | 0 | aromatic ether | |
| d-alpha tocopherol | [no description available] | medium | 1 | 0 | alpha-tocopherol | algal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite |
| nitrites | [no description available] | medium | 2 | 0 | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | human metabolite |
| chloroxylenol | [no description available] | medium | 6 | 0 | monochlorobenzenes;
phenols | antiseptic drug;
disinfectant;
molluscicide |
| chlorine | [no description available] | medium | 6 | 1 | halide anion;
monoatomic chlorine | cofactor;
Escherichia coli metabolite;
human metabolite |
| triclosan | [no description available] | medium | 8 | 0 | aromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols | antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic |
| ketamine | [no description available] | medium | 10 | 0 | cyclohexanones;
monochlorobenzenes;
secondary amino compound | analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic |
| ammonium hydroxide | [no description available] | medium | 4 | 0 | azane;
gas molecular entity;
mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant |
| guanidine | [no description available] | medium | 1 | 0 | carboxamidine;
guanidines;
one-carbon compound | |
| triclocarban | [no description available] | medium | 2 | 0 | dichlorobenzene;
monochlorobenzenes;
phenylureas | antimicrobial agent;
antiseptic drug;
disinfectant;
environmental contaminant;
xenobiotic |
| chlorhexidine | [no description available] | medium | 23 | 1 | biguanides;
monochlorobenzenes | antibacterial agent;
antiinfective agent |
| orabase | [no description available] | medium | 2 | 0 | | |
| edetic acid | [no description available] | medium | 6 | 0 | ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid | anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector |
| silver | [no description available] | medium | 4 | 0 | copper group element atom;
elemental silver | Escherichia coli metabolite |
| scopolamine hydrobromide | [no description available] | medium | 1 | 0 | | |
| fluorine | [no description available] | medium | 1 | 0 | diatomic fluorine;
gas molecular entity | NMR chemical shift reference compound |
| duloxetine hydrochloride | [no description available] | medium | 1 | 0 | duloxetine hydrochloride | antidepressant |
| loceryl | [no description available] | medium | 1 | 0 | morpholine antifungal drug;
tertiary amino compound | EC 1.14.13.132 (squalene monooxygenase) inhibitor;
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor |
| lignin | [no description available] | medium | 1 | 0 | | |
| cellulose | [no description available] | medium | 3 | 0 | glycoside | |
| sulfuric acid | [no description available] | medium | 1 | 0 | sulfur oxoacid | catalyst |
| sodium tetradecyl sulfate | [no description available] | medium | 1 | 0 | | |
| povidone-iodine | [no description available] | medium | 10 | 0 | | |
| vitamin k 3 | [no description available] | medium | 1 | 0 | 1,4-naphthoquinones;
vitamin K | angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical |
| methylparaben | [no description available] | medium | 3 | 0 | paraben | antifungal agent;
antimicrobial food preservative;
neuroprotective agent;
plant metabolite |
| phenoxyethanol | [no description available] | medium | 1 | 0 | aromatic ether;
glycol ether;
primary alcohol | antiinfective agent;
central nervous system depressant |
| 1,2-benzisothiazoline-3-one | [no description available] | medium | 1 | 0 | organic heterobicyclic compound;
organonitrogen heterocyclic compound | disinfectant;
drug allergen;
environmental contaminant;
platelet aggregation inhibitor;
sensitiser;
xenobiotic |
| sodium benzoate | [no description available] | medium | 1 | 0 | organic sodium salt | algal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite |
| thiazoles | [no description available] | medium | 2 | 0 | 1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | |
| propylparaben | [no description available] | medium | 3 | 0 | benzoate ester;
paraben;
phenols | antifungal agent;
antimicrobial agent |
| hydantoins | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | |
| dimethyl sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide;
volatile organic compound | alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger |
| amphotericin b | [no description available] | medium | 1 | 0 | antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic | antiamoebic agent;
antiprotozoal drug;
bacterial metabolite |
| methylbenzethonium chloride | [no description available] | medium | 49 | 0 | alkylbenzene | |
| methylbenzethonium chloride | [no description available] | medium | 49 | 5 | alkylbenzene | |
| phosphorylcholine | [no description available] | medium | 2 | 0 | phosphocholines | allergen;
epitope;
hapten;
human metabolite;
mouse metabolite |
| cetylpyridinium | [no description available] | medium | 5 | 0 | pyridinium ion | |
| cetyltrimethylammonium ion | [no description available] | medium | 2 | 0 | quaternary ammonium ion | |
| phenyl acetate | [no description available] | medium | 3 | 0 | benzenes;
phenyl acetates | |
| aluminum acetate | [no description available] | medium | 1 | 0 | | |
| trichloroethylene | [no description available] | medium | 1 | 0 | chloroethenes | inhalation anaesthetic;
mouse metabolite |
| oleic acid | [no description available] | medium | 1 | 0 | octadec-9-enoic acid | antioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent |
| amiloride | [no description available] | medium | 2 | 0 | aromatic amine;
guanidines;
organochlorine compound;
pyrazines | diuretic;
sodium channel blocker |
| 9-anthroic acid | [no description available] | medium | 1 | 0 | anthroic acid | |
| benzyltrimethylammonium | [no description available] | medium | 1 | 0 | | |
| pyrogallol | [no description available] | medium | 3 | 0 | benzenetriol;
phenolic donor | plant metabolite |
| pyrogallol sulfonphthalein | [no description available] | medium | 3 | 0 | | |
| homogentisic acid | [no description available] | medium | 2 | 0 | dihydroxyphenylacetic acid;
hydroquinones | human metabolite;
plant metabolite |
| tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical |
| mupirocin | [no description available] | medium | 1 | 0 | alpha,beta-unsaturated carboxylic ester;
epoxide;
monocarboxylic acid;
oxanes;
secondary alcohol;
triol | antibacterial drug;
bacterial metabolite;
protein synthesis inhibitor |
| chitosan | [no description available] | medium | 1 | 0 | | |
| propylene glycol | [no description available] | medium | 1 | 0 | glycol;
propane-1,2-diols | allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent |
| hydroxyethylcellulose | [no description available] | medium | 1 | 0 | | |
| su 11248 | [no description available] | medium | 1 | 0 | monocarboxylic acid amide;
pyrroles | angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist |
| pyrroles | [no description available] | medium | 1 | 0 | pyrrole;
secondary amine | |
| paromomycin | [no description available] | medium | 25 | 5 | amino cyclitol glycoside;
aminoglycoside antibiotic | anthelminthic drug;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug |
| acetogenins | [no description available] | medium | 6 | 0 | | |
| glutaral | [no description available] | medium | 7 | 0 | dialdehyde | cross-linking reagent;
disinfectant;
fixative |
| hydroxyproline | [no description available] | medium | 1 | 0 | 4-hydroxyproline;
L-alpha-amino acid zwitterion | human metabolite;
mouse metabolite;
plant metabolite |
| gluma | [no description available] | medium | 1 | 0 | | |
| [2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-(phenylmethyl)ammonium | [no description available] | medium | 1 | 0 | amino acid amide | |
| benzoxonium chloride | [no description available] | medium | 1 | 0 | | |
| benzyl chloride | [no description available] | medium | 1 | 0 | benzyl chlorides | |
| n,o-bis(trimethylsilyl)trifluoroacetamide | [no description available] | medium | 1 | 0 | | |
| farnesol | [no description available] | medium | 3 | 0 | farnesol | plant metabolite |
| vantocil | [no description available] | medium | 1 | 0 | | |
| biguanides | [no description available] | medium | 2 | 1 | guanidines | |
| erythritol | [no description available] | medium | 1 | 0 | butane-1,2,3,4-tetrol | antioxidant;
human metabolite;
plant metabolite |
| xylitol | [no description available] | medium | 1 | 0 | | |
| sorbitol | [no description available] | medium | 1 | 0 | glucitol | cathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent |
| simvastatin | [no description available] | medium | 1 | 0 | delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug |
| 8-aminoquinoline | [no description available] | medium | 1 | 0 | | |
| acetaminophen | [no description available] | medium | 1 | 0 | acetamides;
phenols | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic |
| ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic |
| proguanil | [no description available] | medium | 1 | 0 | biguanides;
monochlorobenzenes | antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
| pempidine | [no description available] | medium | 1 | 0 | piperidines | |
| melitten | [no description available] | medium | 1 | 0 | | |
| trifluoperazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines | antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug |
| nickel | [no description available] | medium | 1 | 0 | metal allergen;
nickel group element atom | epitope;
micronutrient |
| histidine | [no description available] | medium | 1 | 0 | amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite |
| brij-58 | [no description available] | medium | 1 | 0 | | |
| nortriptyline | [no description available] | medium | 1 | 0 | organic tricyclic compound;
secondary amine | adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite |
| fluo-3 | [no description available] | medium | 1 | 0 | xanthene dye | fluorochrome |
| xanthenes | [no description available] | medium | 1 | 0 | xanthene | |
| urea | [no description available] | medium | 7 | 1 | isourea;
monocarboxylic acid amide;
one-carbon compound | Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| glucuronic acid | [no description available] | medium | 1 | 0 | D-glucuronic acid | algal metabolite |
| clay | [no description available] | medium | 1 | 0 | | |
| sepharose | [no description available] | medium | 1 | 0 | | |
| tomatine | [no description available] | medium | 1 | 0 | | |
| piplartine | [no description available] | medium | 1 | 0 | cinnamamides;
dicarboximide | |
| acetic acid | [no description available] | medium | 7 | 0 | monocarboxylic acid | antimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent |
| framycetin | [no description available] | medium | 3 | 0 | aminoglycoside | allergen;
antibacterial drug;
Escherichia coli metabolite |
| tetraoctylammonium bromide | [no description available] | medium | 1 | 0 | | |
| potassium permanganate | [no description available] | medium | 1 | 0 | | |
| aluminum | [no description available] | medium | 1 | 0 | boron group element atom;
elemental aluminium;
metal atom | |
| lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid | algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| thimerosal | [no description available] | medium | 1 | 0 | alkylmercury compound | antifungal drug;
antiseptic drug;
disinfectant;
drug allergen |
| 4-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | monohydroxybenzoic acid | algal metabolite;
plant metabolite |
| meglumine antimoniate | [no description available] | medium | 4 | 3 | | |
| meglumine | [no description available] | medium | 4 | 3 | hexosamine;
secondary amino compound | |
| ruthenium | [no description available] | medium | 1 | 0 | iron group element atom;
platinum group metal atom | |
| 2-phenylphenol | [no description available] | medium | 1 | 0 | hydroxybiphenyls | antifungal agrochemical;
environmental food contaminant |
| methicillin | [no description available] | medium | 1 | 0 | penicillin allergen;
penicillin | antibacterial drug |
| schistoflrfamide | [no description available] | medium | 3 | 0 | | |
| osmium tetroxide | [no description available] | medium | 1 | 0 | osmium coordination entity | fixative;
histological dye;
oxidising agent;
poison |
| alkenes | [no description available] | medium | 1 | 0 | | |
| hydroxyethyl methacrylate | [no description available] | medium | 1 | 0 | enoate ester | allergen;
polymerisation monomer |
| thymol | [no description available] | medium | 3 | 0 | monoterpenoid;
phenols | volatile oil component |
| sodium bicarbonate | [no description available] | medium | 2 | 0 | one-carbon compound;
organic sodium salt | antacid;
food anticaking agent |
| boric acid | [no description available] | medium | 1 | 0 | boric acids | astringent |
| sodium hypochlorite | [no description available] | medium | 1 | 0 | inorganic sodium salt | bleaching agent;
disinfectant |
| chlorobutanol | [no description available] | medium | 2 | 0 | tertiary alcohol | |
| carbamide peroxide | [no description available] | medium | 1 | 0 | mixture | disinfectant;
oxidising agent;
reagent |
| docusate | [no description available] | medium | 2 | 0 | diester;
organosulfonic acid | |
| trichloroacetic acid | [no description available] | medium | 3 | 0 | monocarboxylic acid;
organochlorine compound | carcinogenic agent;
metabolite;
mouse metabolite |
| ethylene oxide | [no description available] | medium | 1 | 0 | gas molecular entity;
oxacycle;
saturated organic heteromonocyclic parent | allergen;
mouse metabolite;
mutagen |
| imiquimod | [no description available] | medium | 1 | 0 | imidazoquinoline | antineoplastic agent;
interferon inducer |
| miltefosine | [no description available] | medium | 1 | 0 | phosphocholines;
phospholipid | anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor |
| antimony sodium gluconate | [no description available] | medium | 1 | 0 | | |
| warfarin | [no description available] | medium | 1 | 0 | benzenes;
hydroxycoumarin;
methyl ketone | |
| muramidase | [no description available] | medium | 1 | 0 | | |
| methanol | [no description available] | medium | 2 | 0 | alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound | amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite |
| perfluorooctanoic acid | [no description available] | medium | 1 | 0 | fluoroalkanoic acid | carcinogenic agent;
endocrine disruptor;
environmental contaminant;
surfactant;
xenobiotic |
| caprylates | [no description available] | medium | 1 | 0 | fatty acid anion 8:0;
straight-chain saturated fatty acid anion | human metabolite;
Saccharomyces cerevisiae metabolite |
| muricatacin | [no description available] | medium | 1 | 0 | long-chain fatty alcohol | |
| ricinoleic acid | [no description available] | medium | 1 | 0 | (9Z)-12-hydroxyoctadec-9-enoic acid | |
| sodium dodecyl sulfate | [no description available] | medium | 4 | 0 | organic sodium salt | detergent;
protein denaturant |
| acetone | [no description available] | medium | 1 | 0 | ketone body;
methyl ketone;
propanones;
volatile organic compound | EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent |
| benzocaine | [no description available] | medium | 2 | 0 | benzoate ester;
substituted aniline | allergen;
antipruritic drug;
sensitiser;
topical anaesthetic |
| sulfosalicylic acid | [no description available] | medium | 2 | 0 | arenesulfonic acid;
benzoic acids;
phenols | metabolite |
| salicylates | [no description available] | medium | 3 | 0 | monohydroxybenzoate | plant metabolite |
| quinidine | [no description available] | medium | 1 | 0 | cinchona alkaloid | alpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker |
| bromphenol blue | [no description available] | medium | 1 | 0 | 2,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
phenols;
sultone | acid-base indicator;
dye;
two-colour indicator |
| quinine | [no description available] | medium | 1 | 0 | cinchona alkaloid | antimalarial;
muscle relaxant;
non-narcotic analgesic |
| berberine | [no description available] | medium | 1 | 0 | alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound | antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker |
| maleic acid | [no description available] | medium | 1 | 0 | butenedioic acid | algal metabolite;
mouse metabolite;
plant metabolite |
| phytic acid | [no description available] | medium | 1 | 0 | inositol phosphate | |
| deoxycholic acid | [no description available] | medium | 1 | 0 | bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid | human blood serum metabolite |
| caseins | [no description available] | medium | 1 | 0 | | |
| fmrfamide | [no description available] | medium | 2 | 0 | | |
| zinc oxide | [no description available] | medium | 3 | 2 | zinc molecular entity | |
| 1-propanol | [no description available] | medium | 2 | 0 | propan-1-ols;
short-chain primary fatty alcohol | metabolite;
protic solvent |
| leucomyosuppressin | [no description available] | medium | 1 | 0 | | |
| masoprocol | [no description available] | medium | 1 | 0 | nordihydroguaiaretic acid | antineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite |
| indomethacin | [no description available] | medium | 1 | 0 | aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole | analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic |
| arachidonic acid | [no description available] | medium | 1 | 0 | icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid | Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite |
| phenylalanyl-leucyl-arginyl phenylalaninamide | [no description available] | medium | 1 | 0 | | |
| palmitic acid | [no description available] | medium | 1 | 0 | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite |
| butyrylthiocholine | [no description available] | medium | 1 | 0 | quaternary ammonium ion | |
| glycine | [no description available] | medium | 2 | 0 | alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical |
| n-vinyl-2-pyrrolidinone | [no description available] | medium | 2 | 0 | pyrrolidin-2-ones | |
| dequalinium | [no description available] | medium | 1 | 0 | quinolinium ion | antifungal agent;
antineoplastic agent;
antiseptic drug;
mitochondrial NADH:ubiquinone reductase inhibitor |
| iodine | [no description available] | medium | 1 | 0 | diatomic iodine | nutrient |
| gentamicin | [no description available] | medium | 2 | 0 | | |
| neutral red | [no description available] | medium | 1 | 0 | hydrochloride | acid-base indicator;
dye;
two-colour indicator |
| diethylmalonic acid | [no description available] | medium | 1 | 0 | | |
| phencyclidine | [no description available] | medium | 1 | 0 | benzenes;
piperidines | anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug |
| arginylphenylalaninamide | [no description available] | medium | 1 | 0 | | |
| neomyosuppressin | [no description available] | medium | 1 | 0 | | |
| agar | [no description available] | medium | 1 | 0 | | |
| formaldehyde | [no description available] | medium | 1 | 0 | aldehyde;
one-carbon compound | allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| nonoxynol | [no description available] | medium | 1 | 1 | | |
| bromthymol blue | [no description available] | medium | 1 | 0 | 2,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone | acid-base indicator;
dye;
two-colour indicator |
| tromethamine | [no description available] | medium | 1 | 0 | primary amino compound;
triol | buffer |
| lysophosphatidylcholines | [no description available] | medium | 1 | 0 | 1-O-acyl-sn-glycero-3-phosphocholine | |
| hydrofluoric acid | [no description available] | medium | 2 | 0 | hydrogen halide;
mononuclear parent hydride | NMR chemical shift reference compound |
| calcium gluconate | [no description available] | medium | 2 | 0 | calcium salt | nutraceutical |
| arsenic | [no description available] | medium | 1 | 0 | metalloid atom;
pnictogen | micronutrient |
| propamidine isethionate | [no description available] | medium | 1 | 0 | guanidinium salt;
organosulfonate salt | antimicrobial agent;
antiseptic drug |
| clotrimazole | [no description available] | medium | 1 | 0 | conazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes | antiinfective agent;
environmental contaminant;
xenobiotic |
| colistin | [no description available] | medium | 1 | 0 | | |
| gentian violet | [no description available] | medium | 1 | 0 | organic chloride salt | anthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye |
| isoprene | [no description available] | medium | 1 | 0 | alkadiene;
hemiterpene;
volatile organic compound | plant metabolite |
| ponceau s | [no description available] | medium | 2 | 0 | organic sodium salt;
organosulfonate salt | fluorochrome;
histological dye |
| hexadecylamine | [no description available] | medium | 1 | 0 | alkylamine | |
| n-tetradecylamine | [no description available] | medium | 1 | 0 | alkylamine | |
| transferrin | [no description available] | medium | 1 | 0 | | |
| biotin | [no description available] | medium | 1 | 0 | biotins;
vitamin B7 | coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite |
| phosphatidylcholines | [no description available] | medium | 2 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
| platinum | [no description available] | medium | 1 | 0 | elemental platinum;
nickel group element atom;
platinum group metal atom | |
| nitric acid | [no description available] | medium | 1 | 0 | nitrogen oxoacid | protic solvent;
reagent |
| nitrates | [no description available] | medium | 1 | 0 | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | |
| camphor, (+-)-isomer | [no description available] | medium | 1 | 0 | bornane monoterpenoid;
cyclic monoterpene ketone | plant metabolite |
| menfegol | [no description available] | medium | 1 | 1 | | |
| tannins | [no description available] | medium | 1 | 0 | | |
| nad | [no description available] | medium | 1 | 0 | organophosphate oxoanion | cofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite |
| thromboxane a2 | [no description available] | medium | 1 | 0 | epoxy monocarboxylic acid;
thromboxanes A | mouse metabolite |
| thromboxane b2 | [no description available] | medium | 1 | 0 | thromboxanes B | human metabolite;
mouse metabolite |
| dinoprost | [no description available] | medium | 1 | 0 | monocarboxylic acid;
prostaglandins Falpha | human metabolite;
mouse metabolite |
| 6-ketoprostaglandin f1 alpha | [no description available] | medium | 1 | 0 | prostaglandins Falpha | human metabolite;
mouse metabolite |
| thromboxanes | [no description available] | medium | 1 | 0 | | |
| 15-keto-13,14-dihydroprostaglandin f2alpha | [no description available] | medium | 1 | 0 | ketone;
prostaglandins Falpha | metabolite |
| phenol | [no description available] | medium | 1 | 0 | phenols | antiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite |
| exudates | [no description available] | medium | 3 | 0 | | |
| zinc oxide | [no description available] | medium | 3 | 0 | | |
| sabinene | [no description available] | medium | 1 | 0 | thujene | plant metabolite |
| tyrphostin ag 1024 | [no description available] | low | 0 | 0 | alkylbenzene | |
| isoxsuprine | [no description available] | low | 0 | 0 | alkylbenzene | |
| nylidrin | [no description available] | low | 0 | 0 | alkylbenzene | |
| oxeladin | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | [no description available] | low | 0 | 0 | alkylbenzene | |
| octoxynol | [no description available] | low | 0 | 0 | alkylbenzene | |
| tyrphostin a9 | [no description available] | low | 0 | 0 | alkylbenzene | geroprotector |
| valethamate | [no description available] | low | 0 | 0 | alkylbenzene | |
| xylometazoline | [no description available] | low | 0 | 0 | alkylbenzene | |
| hydroxyphenamate | [no description available] | low | 0 | 0 | alkylbenzene | |
| isoaminile | [no description available] | low | 0 | 0 | alkylbenzene | |
| phenaglycodol | [no description available] | low | 0 | 0 | alkylbenzene | |
| p-tert-amylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-tert-butylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2,6-di-tert-butyl-4-hydroxymethylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2,4-di-tert-butylphenol | [no description available] | low | 0 | 0 | alkylbenzene;
phenols | antioxidant;
bacterial metabolite;
marine metabolite |
| 4-tert-butylbenzoic acid | [no description available] | low | 0 | 0 | alkylbenzene | |
| cumene | [no description available] | low | 0 | 0 | alkylbenzene | |
| ethylbenzene | [no description available] | low | 0 | 0 | alkylbenzene | |
| n-propylbenzene | [no description available] | low | 0 | 0 | alkylbenzene | |
| n-butylbenzene | [no description available] | low | 0 | 0 | alkylbenzene | |
| proxazole | [no description available] | low | 0 | 0 | alkylbenzene | |
| sec-butylbenzene | [no description available] | low | 0 | 0 | alkylbenzene | |
| sulfurous acid, 2-(p-tert-butylphenoxy)-1-methylethyl 2-chloroethyl ester | [no description available] | low | 0 | 0 | alkylbenzene | |
| 4-tert-octylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| crufomate | [no description available] | low | 0 | 0 | alkylbenzene | |
| isoxsuprine hydrochloride | [no description available] | low | 0 | 0 | alkylbenzene | |
| 4-propylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| promecarb | [no description available] | low | 0 | 0 | alkylbenzene | |
| o-cymen-5-ol | [no description available] | low | 0 | 0 | alkylbenzene | |
| butethamate citrate | [no description available] | low | 0 | 0 | alkylbenzene | |
| butamirate | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2,6-di-tert-butylphenol | [no description available] | low | 0 | 0 | alkylbenzene;
phenols | antioxidant |
| lifibrol | [no description available] | low | 0 | 0 | alkylbenzene | |
| ephedrine hydrochloride | [no description available] | low | 0 | 0 | alkylbenzene | |
| simetride | [no description available] | low | 0 | 0 | alkylbenzene | |
| fenoxazoline | [no description available] | low | 0 | 0 | alkylbenzene | |
| tris-(2,4-di-tert-butylphenyl) phosphite | [no description available] | low | 0 | 0 | alkylbenzene | |
| fenpropimorph | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-(n-myristoylamino)-1-phenyl-1-propanol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 3-(2-hydroxy-4-(1,1-dimethylheptylphenyl)cyclohexan-1-ol) | [no description available] | low | 0 | 0 | alkylbenzene;
ring assembly | |
| 4-propylbenzoic acid | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-n-hexyl-5-n-propylresorcinol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | low | 0 | 0 | alkylbenzene | |
| (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | [no description available] | low | 0 | 0 | alkylbenzene | |
| oxilofrine | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-[(dimethylamino)methyl]-4-methyl-6-(1-methylcyclohexyl)phenol | [no description available] | low | 0 | 0 | alkylbenzene;
ring assembly | |
| 1-(1-azepanyl)-2-(2-bromo-4-propan-2-ylphenoxy)ethanone | [no description available] | low | 0 | 0 | alkylbenzene | |
| N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide | [no description available] | low | 0 | 0 | alkylbenzene | |
| 4-(4-tert-butylphenoxy)-N-(4,5-dihydrothiazol-2-yl)butanamide | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-(2-bromo-4-tert-butylphenoxy)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | alkylbenzene | |
| N-[[[2-(2-bromo-4-propan-2-ylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | alkylbenzene | |
| N-[3-[[diethylamino(sulfanylidene)methyl]thio]-1-oxopropyl]carbamic acid (4-propan-2-ylphenyl) ester | [no description available] | low | 0 | 0 | alkylbenzene | |
| N-[3-[[diethylamino(sulfanylidene)methyl]thio]-1-oxopropyl]carbamic acid (4-tert-butylphenyl) ester | [no description available] | low | 0 | 0 | alkylbenzene | |
| 3-(4-tert-butylphenoxy)-N-(4,5-dihydrothiazol-2-yl)propanamide | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-[[2-[[5-(4-tert-butylphenyl)-2-methoxycarbonyl-3-thiophenyl]amino]-2-oxoethyl]thio]acetic acid | [no description available] | low | 0 | 0 | alkylbenzene | |
| 1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | low | 0 | 0 | alkylbenzene | |
| N-(2-methoxycyclohexyl)-2,5-dimethylaniline | [no description available] | low | 0 | 0 | alkylbenzene | |
| tinofedrine | [no description available] | low | 0 | 0 | alkylbenzene | |
| fospropofol | [no description available] | low | 0 | 0 | alkylbenzene | |
| cgp 13501 | [no description available] | low | 0 | 0 | alkylbenzene | |
| 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | [no description available] | low | 0 | 0 | alkylbenzene;
ring assembly | |
| cgp 7930 | [no description available] | low | 0 | 0 | alkylbenzene | |
| nylidrin hydrochloride | [no description available] | low | 0 | 0 | alkylbenzene | |
| tapentadol | [no description available] | low | 0 | 0 | alkylbenzene | |
| o-demethyltramadol | [no description available] | low | 0 | 0 | alkylbenzene;
ring assembly | |
| elsibucol | [no description available] | low | 0 | 0 | alkylbenzene | |
| 2-(4-butan-2-ylanilino)-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | alkylbenzene | |
| oxaziclomefone | [no description available] | low | 0 | 0 | alkylbenzene | |